In the deep partial-thickness thermal burns treatment market, advancements have revolutionized care, offering substantial benefits. Innovative techniques such as skin substitutes, stem cell therapy, and regenerative medicine have enhanced healing outcomes and minimized scarring. These advancements accelerate wound closure, reduce infection risks, and improve aesthetic results, significantly enhancing patient satisfaction. In addition, emerging technologies such as 3D bioprinting enable customized grafts, further optimizing treatment efficacy. Overall, the continuous evolution of treatments in the deep partial-thickness thermal burns sector enhances patient outcomes and underscores the relentless pursuit of excellence in burn care.
Data Bridge Market Research analyses that the Global Deep Partial-Thickness Thermal Burns Treatment Market size was valued at USD 1.24 billion in 2023, is expected to reach USD 2.32 billion by 2031, at a CAGR of 8.10% during the forecast period 2024 to 2031.
Below are the Top Five Deep Partial-Thickness Thermal Burns Treatment Companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
3M
|
3M is a global leader in innovative solutions, offering various products for various industries, including healthcare. Within deep partial-thickness thermal burns treatment, 3M provides advanced wound care products such as dressings and bandages designed to facilitate healing and prevent infections. Their focus on research and development ensures that their offerings are at the forefront of burn care, providing effective solutions for healthcare professionals.
|
|
America, Middle East and Africa, Europe, Asia-Pacific
|
In October 2019, 3M announced in its company press releases that they completed the acquisition of Acelity, Inc. and its KCI subsidiaries globally, which is focused on advanced wound care and specialty surgical applications. This acquisition was done to improve the company’s wound care solutions.
|
|
2.
|
Smith+Nephew
|
Smith+Nephew is a renowned medical technology company specializing in advanced wound management solutions. Smith+Nephew offers a comprehensive range of products, including dressings, skin grafts, and wound care accessories in the context of deep partial-thickness thermal burns treatment. With a commitment to innovation and quality, Smith+Nephew aims to enhance patient outcomes and improve the standard of care for thermal burn injuries.
|
|
Asia-Pacific, Europe, North America, and Others
|
In April 2018, Smith+Nephew announced on its website that the company released its independent research study on using nanocrystalline silver dressings for burn care wound management, which is very cost-effective and optimizes treatment against infections. This improved company’s new product research and strengthened its position in market.
|
|
3.
|
Johnson & Johnson Services, Inc.
|
Johnson & Johnson Services, Inc. is a multinational corporation known for its diverse portfolio of healthcare products. In treating deep partial-thickness thermal burns, Johnson & Johnson offers a range of advanced wound care solutions, including specialized dressings, topical treatments, and skin substitutes. Leveraging its extensive research capabilities and global reach, Johnson & Johnson strives to provide effective and accessible therapies to address the needs of patients with thermal burn injuries.
|
|
Europe, Middle East and Africa, America, and Asia-Pacific
|
In January 2015, Johnson & Johnson Services, Inc., a Janssen Pharmaceuticals, Inc. parent company, announced that they had acquired the Actelion for USD 30 billion. Actelion will receive USD 280 per Actelion share and will be received in All-Cash Tender Offer launched by Johnson & Johnson. The other share was from a new R&D company. This acquisition helped the company to increase its revenues and the growth rate in the market.
|
|
4.
|
Medline Industries, Inc.
|
Medline Industries, Inc. is a leading manufacturer and distributor of medical supplies and equipment worldwide. In the realm of deep partial-thickness thermal burns treatment, Medline offers a comprehensive array of wound care products, including dressings, ointments, and specialized bandages. Focusing on innovation and quality, Medline aims to support healthcare professionals in delivering optimal care to patients with thermal burn injuries, facilitating healing and minimizing complications.
|
|
Europe, North America
|
In March 2021, Medline industries, Inc announced that they have been awarded a prime vendor contract to serve as the exclusive supply vendor for Windsor Lane Health Care. This Ohio-based long-term care facility has increased its supply chain in U.S.
|
|
5.
|
Convatec Group PLC
|
Convatec Group PLC is a global medical products and technologies company specializing in wound care, ostomy care, and continence care. In the context of deep partial-thickness thermal burns treatment, Convatec offers a range of advanced wound dressings, skin grafts, and therapeutic support surfaces designed to promote healing and reduce the risk of complications. Through continuous innovation and collaboration with healthcare providers, Convatec is committed to improving outcomes for patients with thermal burn injuries, enhancing their quality of life and recovery journey.
|
|
North America, Middle East and Africa, South America, Europe, Asia-Pacific
|
In September 2019, ConvaTec Inc. announced in its press releases that the company acquired Southlake Medical Supplies, Inc.'s assets, which a provider of catheter-related products in Texas. This enhanced company’s manufacturing facility and strengthened its footprint in the market further.
|
Conclusion
In conclusion, the deep partial-thickness thermal burns treatment market shows promising growth prospects driven by technological advancements and rising incidence rates. Opportunities lie in developing innovative therapies and the increasing adoption of advanced wound care solutions. As the demand for effective treatments escalates, stakeholders can capitalize on these trends to enhance patient outcomes and drive market expansion. Embracing these drivers will be pivotal in shaping the future landscape of burn care.
